Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Repair Stem Cell Institute (RSCI) is a healthcare organization that functions as an information clearinghouse and patient advocacy group for adult stem cell treatments. The institute focuses on connecting patients with chronic and debilitating conditions to medical centers worldwide that provide adult stem cell therapies, specifically autologous or umbilical cord-derived cells. RSCI advocates for the clinical application of adult stem cells over embryonic stem cells, emphasizing safety and ethical considerations. Their services include patient education, treatment referrals, and the monitoring of clinical outcomes across a wide range of indications, including cardiovascular, neurological, and autoimmune disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Repair Stem Cell Institute.